EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity

Bhargavi Narayanan, Prithvi Sinha, Roger Henry, Russell A Reeves, Nazareno Paolocci, Mark J Kohr, Natasha E Zachara

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.105447 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Bhargavi Narayanan und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Biological Chemistry at the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Acetylglucosamine, Heart, Myocardium, N-Acetylglucosaminyltransferases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The post-translational modification of intracellular proteins by O-linked β-GlcNAc (O-GlcNAc) has emerged as a critical regulator of cardiac function. Enhanced O-GlcNAcylation activates cytoprotective pathways in cardiac models of ischemia-reperfusion (I/R) injury; however, the mechanisms underpinning O-GlcNAc cycling in response to I/R injury have not been comprehensively assessed. The cycling of O-GlcNAc is regulated by the collective efforts of two enzymes: O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), which catalyze the addition and hydrolysis of O-GlcNAc, respectively. It has previously been shown that baseline heart physiology and pathophysiology are impacted by sex. Here, we hypothesized that sex differences in molecular signaling may target protein O-GlcNAcylation both basally and in ischemic hearts. To address this question, we subjected male and female WT murine hearts to ex vivo ischemia or I/R injury. We assessed hearts for protein O-GlcNAcylation, abundance of OGT, OGA, and glutamine:fructose-6-phosphate aminotransferase (GFAT2), activity of OGT and OGA, and UDP-GlcNAc levels. Our data demonstrate elevated O-GlcNAcylation in female hearts both basally and during ischemia. We show that OGT activity was enhanced in female hearts in all treatments, suggesting a mechanism for these observations. Furthermore, we found that ischemia led to reduced O-GlcNAcylation and OGT-specific activity. Our findings provide a foundation for understanding molecular mechanisms that regulate O-GlcNAcylation in the heart and highlight the importance of sex as a significant factor when assessing key regulatory events that control O-GlcNAc cycling. These data suggest the intriguing possibility that elevated O-GlcNAcylation in females contributes to reduced ischemic susceptibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylglucosamineHeartMyocardiumN-AcetylglucosaminyltransferasesSex CharacteristicsSignal TransductionAnimalsFemaleMaleMiceIschemiaProtein Processing, Post-TranslationalGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)

Stichwörter der Autor:innen

O-GlcNAcO-GlcNAc transferaseO-GlcNAcasecardiacglycosylationhexosamine biosynthetic pathwaysex differences

Substanzen

AcetylglucosamineN-AcetylglucosaminyltransferasesGFPT2 protein, mouseGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)O-GlcNAc transferaseOgt protein, mouse

Autor:innen und Institutionen

  • The Department of Biological Chemistry at the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • The Department of Environmental Health and Engineering, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Biomedical Sciences, University of Padova, Padua, Italy.
  • The Department of Biological Chemistry at the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Department of Oncology at the Johns Hopkins University School of Medicine, Baltimore, Maryland, US…

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Narayanan, B., Sinha, P., Henry, R., Reeves, R. A., Paolocci, N., Kohr, M. J., & Zachara, N. E. (2023). Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105447

Vancouver

Narayanan B, Sinha P, Henry R, Reeves RA, Paolocci N, Kohr MJ, et al. Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105447

BibTeX
@article{Narayanan2023,
  author = {Narayanan, Bhargavi and Sinha, Prithvi and Henry, Roger and Reeves, Russell A and Paolocci, Nazareno and Kohr, Mark J and Zachara, Natasha E},
  title = {Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.105447}
}
Kostenlos starten →